Assessment of the Effect of Treatment with Neoadjuvant Chemotherapy on Breast Cancer Axillary Lymph Node
References
- 1. Bear HD. Indication for neoadjuvant chemotherapy for breast cancer. Semin Oncol. 1998; 25(2 Suppl3):3-12.
- 2. Botti C,Vici P, Lopez M, Scinto AF, Cognetti F, Cavaliere R. Prognotic value of lymph node metastasis after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast. J Am CollSurg. 1995; 181 (3):202-208.
- 3. Kuerer HM, Newman LA, Buzdar AU, Hunt KK, Dhingra K, Buchholz TA, et al. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. AmJ Surg. 1998;76:502-506.
- 4. Kuerer HM, Newman LA, Fomage BD, Dhingra K, Hunt KK, Buzdar AU, et al. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Ann Surg Oncol. 1998;5(3):673-80.
- 5. Machiavelli MR, Romero AO, Perez JE, Lacava JA, Dominguez ME, Rodriguez R, et al. Prognostic significance of pathological response of primary tumour and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma. Cancer J Sci Am. 1998 ;4(2):125-31.
- 6. Feldman LD, Hortobagyi GN, Buzdar AU, Ames FC, Blumenschein GR. Pathological assessment of response to induction chemotherapy in breast cancer.CancerRes. 1986;46(5):2578-81.
- 7. Gazet J-C,Coombes RC, Ford HT, Griffin M, Coibishley C, Makinde V, et al. Assessment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer. Br J Cancer. 1996; 73(6): 758-762.
- 8. Kennedy SM, Merino MJ, Swain S, Lippman ME. The effect of hormonal and chemotherapy on tumoral and non-neoplastic breast tissue. Hum Pathol. 1990;21(2): 192 -8.
- 9. Khanna AK, Saxena SK, Khan a S, Kumar A. Histopathological changes following anterior chemotherapy in advanced breast cancer. Ind J Cancer. 1990;27(2):109-15.
- 10. Khanna AK, Saxena SK, Khan a S, and Mistra MK:Tumor response to chemotherapy as a primary treatment in advanced breast cancer. Ind J Slug. 1991;53(6):239-45.
- 11. Mortimer JE, Taylor ME. Can chemotherapy alter the histologic features of breast cancer. Am J Clin PathoL 1994; 102(2): 147-9.
- 12. Moll UM, Chumas J. Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer. Pathol Res Pract. 1997; 193(3): 187-96.
- 13. Hayward JL, Carbone PP, Heusen JC, Kumaoka S, Segaloff A, Rubens RD. Assessment of response to therapy in advanced breast cancer. Br J Cancer. 1977;35:292-8.
- 14. WHO Handbook for Reporting Results of Cancer Treatment WHO Offset publication No. 48. Geneva: World Health Organization; 1979.
- 15. Sinn HP, Schmod H, Junkermann H, Huober J, Leppien G, Kaufmann M, et al. Histologische regression des ma mmac arzino mas nach primarer (neoadjuvanter) chemotherapie. Geburtsh Frauenheilk. 1994;54(10):552-8.
- 16. Gampenrieder SP, Rinnerthaler G, Greil R. Neoadjuvant chemotherapy and targeted therapy in breast cancer past, present, and future. J Oncol. 2013;2013:732047.
- 17. Honkoop AH, Pinedo HM, De Jong de JS, Verheul HM, Linn SC, Hoekman K, et al. Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. Am J Clin Pathol. 1997; 107(2):211-8.
- 18. Sharkey FE, Addington SL, Flowerl J, Page CP, Cruz AB. Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol. 1996;9(9):893-900.
- 19. Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg. 1999;230(l):72-78.
- 20. Lenert JT, Vlastos G, Mirza NQ, Winchester DJ, Binkley SM, Ames FC, et al. Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients. Ann Surg Oncol. 1999;6(8):762-7.
- 21. Paradinas FJ. Primary and secondary breast disorders. In: StansfeldAG, d'Ardene AJ, editors. Lymph node biopsy interpretation. 2nd ed. Edinburgh: Churchill Livingstone; 1992. p. 171-86.
- 22. Sahoo S, Lester SC. Pathology of breast carcinomas after neoadjuvant chemotherapy: an overview with recommendations on specimen processing and reporting. Arch Pathol Lab Med. 2009; 133(4):633-42.
- 23. Pinder SE, Ptovenzano E, Earl H, Ellis IO. Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy. Histopathology. 2007;50(4):409-17.
- 24. Azzopardi JG, Ahmed A, Millis RR. Problems in breast pathology. Major Probl Pathol. 1979;11:1-466.
- 25. Misdorp W, Hart G, Delemarre JFM, Voute PA, van der Eijken JW. An analysis of spontaneous and chemotherapy-associated changes in skeletal osteosarcomas. J Pathol. 1988; 156(2): 119-28.
- 26. Rosen G, Capparos B, Huvos AG, Kosloff C, Nirenbetg A, Cacavio A, et al. Preoperative chemotherapy for osteogenic sarcoma:selection of postoperative chemotherapy based on response of the primary tumor to preoperative chemotherapy. Cancer. 1982;49(6): 1221-30.
DOI: https://doi.org/10.1515/jbcr-2015-0106 | Journal eISSN: 1313-9053
Language: English
Page range: 82 - 88
Submitted on: Nov 18, 2013
Accepted on: Dec 27, 2013
Published on: Nov 30, 2016
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Related subjects:
© 2016 Savelina L. Popovska, Ivan N. Ivanov, Dorian Y. Dikov, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.